Total Raised

$90K

Investors Count

3

Funding, Valuation & Revenue

3 Fundings

Tyche has raised $90K over 3 rounds.

Tyche's latest funding round was a Incubator/Accelerator for $0.02M on July 24, 2017.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

7/24/2017

Incubator/Accelerator

$0.02M

$XXM

0

FY undefined

1

2/18/2015

Seed - II

$XXM

$XXM

0

FY undefined

10

9/26/2014

Seed

$XXM

$XXM

0

FY undefined

10

Date

7/24/2017

2/18/2015

9/26/2014

Round

Incubator/Accelerator

Seed - II

Seed

Amount

$0.02M

$XXM

$XXM

Investors

Valuation

$XXM

$XXM

$XXM

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

Sources

1

10

10

Start free trial
New call-to-action

Tyche Investors

3 Investors

Tyche has 3 investors. Swiss Re Insurtech Accelerator invested in Tyche's Incubator/Accelerator funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

7/24/2017

7/24/2017

1
Incubator/Accelerator

Incubator/Accelerator

Switzerland

00/00/0000

00/00/0000

Global Insurance Accelerator

Subscribe to see more

Incubator/Accelerator

Iowa

00/00/0000

00/00/0000

Alchemist Accelerator

Subscribe to see more

Incubator/Accelerator

Florida

First funding

7/24/2017

00/00/0000

00/00/0000

Last Funding

7/24/2017

00/00/0000

00/00/0000

Investor

Global Insurance Accelerator

Alchemist Accelerator

Rounds

1
Incubator/Accelerator

Subscribe to see more

Subscribe to see more

Board Seats

Type

Incubator/Accelerator

Incubator/Accelerator

Incubator/Accelerator

Location

Switzerland

Iowa

Florida

New call-to-action

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.